|
Disorder
|
Diagnostic Parameters
|
|
Adrenoleukodystrophy, X-linked (4)
|
Plasma very long chain fatty acid ratios and mutation analysis
|
|
Adrenomyeloneuropathy
|
Plasma very long chain fatty acid ratios and mutation analysis
|
|
Congenital disorder of glycosylation type Ia
|
Transferrin isoforms and phophomannomutase activity
|
|
Cystic fibrosis (3)
|
Mutation analysis
|
|
Galactosialidosis
|
Neuraminidase and b-galactosidase activity
|
|
Gaucher disease (2)
|
β-glucocerebrosidase activity and mutation analysis |
|
Glucose storage disease Ia
|
Liver glucose-6-phosphatase activity
|
|
I-cell disease
|
Plasma lysosomal enzyme activities
|
|
Ichthyosis, X-linked
|
Steroid sulphatase
|
|
Krabbe disease (3)
|
β-galactocerebrosidase activity |
|
Late-infantile neuronal ceroid lipofuscinosis
|
Tripeptidyl peptidase I activity
|
|
MPS I
|
Urine mucopolysaccharide screen, a-L-iduronidase activity
|
|
MPS II (12)
|
Urine mucopolysaccharide screen, iduronate-2-sulphatase activity and mutation analysis
|
|
MPS IIIA (2)
|
Urine mucopolysaccharide screen, sulphamidase activity and mutation analysis
|
|
MPS IIIB
|
Urine mucopolysaccharide screen, a-N-acetylglucosaminidase activity
|
|
MPS IVA
|
Urine mucopolysaccharide screen, N-acetylgalactose-6-sulphatase activity
|
|
Niemann-Pick disease type C (2)
|
Cholesterol esterification and filipin staining
|
|
Niemann-Pick disease types A&B (3)
|
Sphingomyelinase activity
|
|
Peroxisomal biogenesis disorder (2)
|
Plasma very long chain fatty acid ratios and peroxisomal enzyme analysis
|
|
Peroxisomopathy
|
Plasma very long chain fatty acid ratios and peroxisomal enzyme analysis
|
|
Pompe disease (3)
|
α-1,4-glucosidase activity |
|
Primary hyperoxaluria type I
|
Glyoxalate aminotransferases
|
|
Sandhoff disease (2)
|
Total b-hexosaminidase activity
|
|
Tay-Sachs disease
|
β-hexosaminidase A activity |